Monitor for any future conversion to a Schedule 13D, which would signal activist intent. For now, the passive filing suggests no near-term catalyst from this holder.
Price Chart
Executive Summary
HBM Healthcare Investments (Cayman) Ltd. filed a Schedule 13G disclosing a passive 8% beneficial ownership stake in Vicore Pharma Holding AB as of October 13, 2026. The fund holds 22,505,819 common shares and has no intent to influence control, consistent with a passive investment in a clinical-stage pharmaceutical company.
Key Financial Metrics
Key Facts
- HBM Healthcare Investments (Cayman) Ltd. holds 22,505,819 common shares of Vicore Pharma, representing approximately 8% of shares outstanding.
- The filing is a Schedule 13G, indicating passive investment intent with no plan to influence management.
- The stake is based on 281,644,509 common shares outstanding as of September 30, 2026.
- The reporting person is a Cayman Islands entity, likely a healthcare-focused investment fund.
- This appears to be an initial 13G filing (not an amendment), as no prior filing is referenced.
Financial Impact
8% passive stake in Vicore Pharma; no transaction value disclosed.
Risk Factors
- Potential future conversion to 13D could signal activist pressure.
- No material financial impact from this passive disclosure alone.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-115489 |
| Document: 0001104659-26-115489-index.html | 0001104659-26-115489 |
| Document: 0001104659-26-115489.txt | 0001104659-26-115489 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $9.38 $9.40 | ▲ +0.21% | ▼ −0.50% | $9.38 (+0.00%) |
Oct 13, 2026 13d ago | SC 13G | $9.08 $9.09 | ▲ +0.11% | ▼ −0.17% | $9.38 (+3.30%) |
Sep 30, 2026 26d ago | 6-K | $9.43 $9.33 | ▼ −1.06% | ▼ −1.80% | $9.38 (−0.53%) |
Jul 6, 2026 16w ago | 6-K | $16.25 $15.03 | ▼ −7.54% | ▼ −7.06% | $9.38 (−42.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers